Bavarian Nordic says Phase 2 trial supports EU approval of IMVANEX mpox vaccine in children 2-11PUBT·Aug 7 at 01:00 AMBVNRY+0.95%
Bavarian Nordic partner files chikungunya vaccine for Brazil Anvisa approvalPUBT·Jul 13 at 08:26 AMBVNRY+0.95%
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goalrttnews·Jul 2 at 09:15 AMNVS+1.70%VRTX+2.45%
Bavarian Nordic – Transactions in Connection with Share Buy-Back ProgramUnusual Whales·Jun 15 at 01:49 AMBVNRY+0.95%
Bavarian Nordic Wins DKK 700 Million Smallpox/Mpox Vaccine Supply Contractrttnews·Jun 9 at 06:19 AMBVNRY+0.95%
Bavarian Nordic (CPSE:BAVA) Q1 Margin Squeeze Challenges Bullish Profitability NarrativeSimplywall·May 15 at 01:18 AMBVNRY+0.95%VHT+1.43%
Bavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Orderrttnews·May 12 at 01:14 AMBVNRY+0.95%
